(Q31167338)

29 June 2017

title

Cost effectiveness of current approaches to the control of retinopathy in type I diabetics (English)

1 reference

cost-effectiveness analysis

29 June 2017

main subject

1 reference

Javitt JC

1

1 reference

29 June 2017

Canner JK

series ordinal

2

1 reference

29 June 2017

Sommer A

series ordinal

3

1 reference

29 June 2017

publication date

1 February 1989

1 reference

29 June 2017

1 reference

29 June 2017

volume

96

1 reference

29 June 2017

issue

2

1 reference

29 June 2017

page(s)

255-264

1 reference

Four risk factors for severe visual loss in diabetic retinopathy. The third report from the Diabetic Retinopathy Study. The Diabetic Retinopathy Study Research Group

29 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932923-X

7 January 2021

Photocoagulation for Diabetic Macular Edema

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932923-X

7 January 2021

Photocoagulation for diabetic macular edema

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932923-X

7 January 2021

Incidence of diabetes mellitus by clinical type

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932923-X

7 January 2021

Risk of proliferative diabetic retinopathy in juvenile-onset type I diabetes: a 40-yr follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932923-X

7 January 2021

A population-based study of diabetic retinopathy in insulin-using patients diagnosed before 30 years of age.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932923-X

7 January 2021

Retinopathy in young-onset diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932923-X

7 January 2021

The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932923-X

7 January 2021

The Natural History of Retinopathy in Insulin-Dependent Juvenile-Onset Diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932923-X

7 January 2021

Incidence of diabetic retinopathy and blindness: a population-based study in Rochester, Minnesota

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932923-X

7 January 2021

Estimating incidence from age-specific prevalence for irreversible diseases with differential mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932923-X

7 January 2021

The Wisconsin epidemiologic study of diabetic retinopathy. IV. Diabetic macular edema

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932923-X

7 January 2021

Macular edema in Diabetic Retinopathy Study patients. Diabetic Retinopathy Study Report Number 12

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932923-X

7 January 2021

Psychosocial aspects of diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932923-X

7 January 2021

LONGEVITY AND MORTALITY OF DIABETICS

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932923-X

7 January 2021

The Pittsburgh insulin-dependent diabetes mellitus (IDDM) morbidity and mortality study. Mortality results.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932923-X

7 January 2021

The efficacy of additional argon laser photocoagulation for persistent, severe proliferative diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932923-X

7 January 2021

10.1016/S0161-6420(89)32923-X

Identifiers

DOI

0 references

1 reference